FGFR3 contributes to intestinal crypt cell growth arrest
- 19 February 2008
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 216 (1) , 261-268
Abstract
Fibroblast growth factors (FGFs) are important regulators of the dynamic development and turnover of tissues. Among FGF receptors, FGFR3 expression is confined in the intestinal crypts. We examined FGFR3‐deficient mice and saw increased intestinal crypt depth but no change in villae length or in the distribution of differentiated intestinal cells, suggesting that the impact of lack of FGFR3 was limited to the progenitor cell compartment. Accordingly, enhancement of intestinal crypt proliferation was observed in FGFR3 mutant mice and interestingly, upon anti‐FGFR3 antibody administration in wild type mice. Moreover, injection of FGF18, a ligand of FGFR3, in wild type mice resulted in decreased cell proliferation within the intestinal crypts. In addition, we found that ERK level of activation was increased in FGFR3‐deficient intestinal epithelium. In vitro studies showed that ERK, AKT and activation was regulated by FGFs and that ERK level of activation was inversely correlated to FGFR3 level of expression in the intestinal crypt cells. Furthermore, effects of FGF18 on ERK and AKT activation paralleled FGFR3 effects on these intracellular targets. Our data indicate that FGF18 and FGFR3 are involved, possibly as partners, in the control of intestinal precursor cell proliferation. J. Cell. Physiol. 216: 261–268, 2008.Keywords
This publication has 37 references indexed in Scilit:
- FGFR3 Is a Negative Regulator of the Expansion of Pancreatic Epithelial CellsDiabetes, 2007
- The fibroblast growth factor pathway serves a regulatory role in proliferation and apoptosis in the pathogenesis of intestinal atresiaJournal of Pediatric Surgery, 2006
- Fibroblast Growth Factor (FGF) 18 Signals through FGF Receptor 3 to Promote ChondrogenesisJournal of Biological Chemistry, 2005
- Heterogeneity in Primary and Metastatic Prostate Cancer as Defined by Cell Surface CD ProfileThe American Journal of Pathology, 2004
- The phosphotyrosine phosphatase SHP2 is a critical mediator of transformation induced by the oncogenic fibroblast growth factor receptor 3Oncogene, 2003
- Neoplasms associated with alterations in fibroblast growth factor receptorsAmerican Journal of Medical Genetics Part A, 2003
- Rapid mitogen-activated protein kinase by basic fibroblast growth factor in rat intestine after ischemia/reperfusion injuryWorld Journal of Gastroenterology, 2003
- Transimmortalized mouse intestinal cells (m-ICc12) that maintain a crypt phenotypeAmerican Journal of Physiology-Cell Physiology, 1996
- Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3Nature Genetics, 1996
- Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract.Journal of Clinical Investigation, 1994